Home › Funds › Amova Asset Management Americas, Inc. › CRSP

Amova Asset Management Americas, Inc. position in CRSP

CRISPR THERAPEUTICS AG · Health Care

Amova Asset Management Americas, Inc. reported holding 1,453,513 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q3 2026 13F filing — a position valued at US$80.4M, representing 1.00% of its reported portfolio and ranking #32 among its reported holdings. Amova Asset Management Americas, Inc. has disclosed CRSP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.45M sh
Reported value held$80.36M
Portfolio Weight1.00%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Amova Asset Management Americas, Inc.'s CRSP position evolved

Amova Asset Management Americas, Inc. first disclosed a stake in CRSP in Q3 2023 at 3,465,470 shares (US$157.3M). The position peaked in Q1 2024 at 3,268,785 shares, worth US$222.7M. Across 13 filings, Amova Asset Management Americas, Inc. increased the stake 0 time(s), trimmed it 12 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,453,513 shares valued at US$80.4M — a reduction of -266,584 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.47M $157.26M New
Q4 2023 3.37M $210.91M Reduce
Q1 2024 3.27M $222.70M Reduce
Q2 2024 3.15M $169.99M Reduce
Q3 2024 2.97M $139.37M Reduce
Q4 2024 2.75M $108.07M Reduce
Q1 2025 2.54M $86.33M Reduce
Q2 2025 2.41M $117.38M Reduce
Q3 2025 2.16M $140.18M Reduce
Q4 2025 1.96M $102.61M Reduce
Q1 2026 1.85M $88.19M Reduce
Q2 2026 1.72M $93.76M Reduce
Q3 2026 1.45M $80.36M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRSP and 13F data

CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 29 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$556.3M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$144.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRSP

All CRSP fund holders →

FAQ

How long has Amova Asset Management Americas, Inc. held CRSP?

Amova Asset Management Americas, Inc. has disclosed CRSP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Amova Asset Management Americas, Inc.'s current position in CRSP?

As of Q3 2026, Amova Asset Management Americas, Inc. holds 1.45M shares of CRSP (CRISPR THERAPEUTICS AG), valued at $80.36M, representing 1.00% of its reported portfolio and ranking #32.

Has Amova Asset Management Americas, Inc. been buying or selling CRSP?

In the latest 13F filing (Q3 2026), Amova Asset Management Americas, Inc. reduced its position in CRSP. The position peaked in Q1 2024 at 3.27M shares.

Which other funds hold CRSP?

Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.